Literature DB >> 19584349

The need for improved access to FDA reviews.

Alec B O'Connor1.   

Abstract

Mesh：

Year:  2009        PMID： 19584349     DOI： 10.1001/jama.2009.973

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  The importance of FDA approval packages and briefing documents in pharmacy education.

Authors:  Larry D Sasich; Sana R Sukkari; G Elliott Cook; Donald A Tuttle
Journal:  Am J Pharm Educ       Date:  2009-11-12       Impact factor: 2.047

2.  Different black box warning labeling for same-class drugs.

Authors:  Orestis A Panagiotou; Despina G Contopoulos-Ioannidis; Panagiotis N Papanikolaou; Evangelia E Ntzani; John P A Ioannidis
Journal:  J Gen Intern Med       Date:  2011-02-01       Impact factor: 5.128

3.  Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website.

Authors:  Jisna R Paul; Prabha Ranganathan
Journal:  Rheumatol Int       Date:  2011-07-19       Impact factor: 2.631

4.  Outcome reporting among drug trials registered in ClinicalTrials.gov.

Authors:  Florence T Bourgeois; Srinivas Murthy; Kenneth D Mandl
Journal:  Ann Intern Med       Date:  2010-08-03       Impact factor: 25.391

5.  FDA regulation of cardiovascular devices and opportunities for improvement.

Authors:  Sanket S Dhruva; Rita F Redberg
Journal:  J Interv Card Electrophysiol       Date:  2012-12-21       Impact factor: 1.900

Review 6.  Risks of phase I research with healthy participants: A systematic review.

Authors:  Rebecca A Johnson; Annette Rid; Ezekiel Emanuel; David Wendler
Journal:  Clin Trials       Date:  2015-09-08       Impact factor: 2.486

7.  Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Authors:  Richard T Scheife; Lisa E Hines; Richard D Boyce; Sophie P Chung; Jeremiah D Momper; Christine D Sommer; Darrell R Abernethy; John R Horn; Stephen J Sklar; Samantha K Wong; Gretchen Jones; Mary L Brown; Amy J Grizzle; Susan Comes; Tricia Lee Wilkins; Clarissa Borst; Michael A Wittie; Daniel C Malone
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

Review 8.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

9.  Medical device regulation: time to improve performance.

Authors:  Sanket S Dhruva; Rita F Redberg
Journal:  PLoS Med       Date:  2012-07-31       Impact factor: 11.069

10.  Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal.

Authors:  Kan Yonemori; Akihiro Hirakawa; Masashi Ando; Taizo Hirata; Mayu Yunokawa; Chikako Shimizu; Kenji Tamura; Yasuhiro Fujiwara
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.